SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003735
Filing Date
2021-03-30
Accepted
2021-03-30 17:28:44
Documents
115
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K casi-20201231x10k.htm   iXBRL 10-K 2297728
2 EX-4.1 casi-20201231xex4d1.htm EX-4.1 22475
3 EX-10.4 casi-20201231xex10d4.htm EX-10.4 413909
4 EX-10.5 casi-20201231xex10d5.htm EX-10.5 403305
5 EX-10.6 casi-20201231xex10d6.htm EX-10.6 389477
6 EX-10.8 casi-20201231xex10d8.htm EX-10.8 1262313
7 EX-10.29 casi-20201231xex10d29.htm EX-10.29 39887
8 EX-10.30 casi-20201231xex10d30.htm EX-10.30 478800
9 EX-21 casi-20201231xex21.htm EX-21 3223
10 EX-23.1 casi-20201231xex23d1.htm EX-23.1 3194
11 EX-31.1 casi-20201231xex31d1.htm EX-31.1 9823
12 EX-31.2 casi-20201231xex31d2.htm EX-31.2 10280
13 EX-32.1 casi-20201231xex32d1.htm EX-32.1 6153
14 EX-32.2 casi-20201231xex32d2.htm EX-32.2 6215
15 GRAPHIC casi-20201231xex10d29001.jpg GRAPHIC 4709
16 GRAPHIC casi-20201231xex10d30002.jpg GRAPHIC 5122
17 GRAPHIC casi-20201231xex10d30003.jpg GRAPHIC 5904
18 GRAPHIC casi-20201231x10k001.jpg GRAPHIC 2150
  Complete submission text file 0001558370-21-003735.txt   13757027

Data Files

Seq Description Document Type Size
19 EX-101.SCH casi-20201231.xsd EX-101.SCH 80448
20 EX-101.CAL casi-20201231_cal.xml EX-101.CAL 75176
21 EX-101.DEF casi-20201231_def.xml EX-101.DEF 325506
22 EX-101.LAB casi-20201231_lab.xml EX-101.LAB 612257
23 EX-101.PRE casi-20201231_pre.xml EX-101.PRE 582860
24 EXTRACTED XBRL INSTANCE DOCUMENT casi-20201231x10k_htm.xml XML 1728776
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20713 | Film No.: 21788353
SIC: 2836 Biological Products, (No Diagnostic Substances)